Akbal-Dagistan, O. Et Al. 2022. Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects. PHARMACEUTICS , vol.14, no.11 .

Akbal-Dagistan, O., Sevim, M., Sen, L. S., Basarir, N. S., Culha, M., Erturk, A., ... Fael, H.(2022). Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects. PHARMACEUTICS , vol.14, no.11.

Akbal-Dagistan, Ozlem Et Al. "Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects," PHARMACEUTICS , vol.14, no.11, 2022

Akbal-Dagistan, Ozlem Et Al. "Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects." PHARMACEUTICS , vol.14, no.11, 2022

Akbal-Dagistan, O. Et Al. (2022) . "Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects." PHARMACEUTICS , vol.14, no.11.

@article{article, author={Ozlem Akbal-Dagistan Et Al. }, title={Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects}, journal={PHARMACEUTICS}, year=2022}